Tldr: The AstraZeneca vaccine, which uses an adenovirus to smuggle instructions into human cells to make antibodies against the novel coronavirus, has saved countless lives. However, a tiny proportion of those vaccinated developed blood clots. This blood clot syndrome is known as vaccine-induced immune thrombotic thrombocytopenia (VITT). In people with this condition, something goes wrong with the immune response and people make antibodies that can stick to one of the body’s own proteins. Researchers believe that a variation of a gene that makes parts of antibodies is linked to VITT and this is more common in people of European descent .
thanks although I wonder why the mrna versions seem to avoid it.
In the early days of UK roll out. When we started to hear news of clots happening. The actual numbers indicated Pfizer was seeing slightly more clots per dose. Still tiny tiny numbers of people effected. But AZ was the only one that faced the EU rejection from those results.
I am curious how and if that data changed as more doses were given.
Ooi if you have any knowledge. I remember this all being discovered (the clots not the cause) in the early days of the first roll out.
But also remember that when the figures were looked at. Other vacines from Pfizer actually had higher numbers per dose. (Still tiny to low to draw conclusions for any at the time.). But did not get the rejections from the EU that AZ did.
Do you know weather those stats continued into further doses. Or is AZ the only one that is the actual cause of clots rather then clots happening as doses were given.
